Jason is Global President of Inizio’s first enterprise business unit, Inizio Biotech.
Jason and his team enable our biotech partners to maximize the value of their asset by providing scalable support, through the seamless experience of a single point of coordination.
Previously CEO at STEM, an Inizio Advisory company, Jason led the organization through significant scaling and transformation throughout the COVID pandemic. He also spent the initial part of his career in big pharma working for AstraZeneca in the US and UK across a variety of marketing, sales and finance roles.
